| Structure |
Chemical Name |
CAS |
MF |
 |
rac 5-Keto Fluvastatin |
1160169-39-0 |
C24H24FNO4 |
 |
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
 |
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED |
911661-90-0 |
C21H13I6NO5 |
 |
ペリンドプリルジケトピペラジン |
129970-98-5 |
C19H30N2O4 |
 |
Exemestane Impurity A |
|
|
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/629652-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
629652-44-4 |
C22H19ClN2O5 |
 |
3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib |
847949-56-8 |
C20H22ClFN4O3 |
 |
2,4-ビス(2-フラニルメチルアミノ)-5-スルファモイル安息香酸 |
5046-19-5 |
C17H17N3O6S |
 |
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
 |
(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル |
86153-39-1 |
C20H25NO3 |
![2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-44-6.gif) |
2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity |
116182-44-6 |
C26H43NaO9 |
 |
3-Hydroxy CitalopraM |
411221-53-9 |
C20H21FN2O2 |
 |
5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール |
58457-32-2 |
C15H17NO2 |
 |
6α-Methyl Hydrocortisone 21-HeMisuccinate |
119657-85-1 |
C26H36O8 |
 |
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
 |
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
 |
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
 |
2-フルオロビフェニル-4-カルボン酸 |
137045-30-8 |
C13H9FO2 |
 |
テオフィルリジン塩酸塩 |
116131-08-9 |
C6H10ClN4O |
 |
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
 |
Tetracyclics compound impurities |
|
|
 |
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
 |
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
 |
3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
85175-65-1 |
C15H20ClNO3 |
 |
N-DesMethyl TelMisartan |
144701-81-5 |
C32H28N4O2 |
![N-De[2-(Methylsulfonyl)ethyl] Lapatinib](/CAS/GIF/697299-82-4.gif) |
N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
697299-82-4 |
C26H20ClFN4O2 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide](/CAS/GIF/957470-58-5.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide |
957470-58-5 |
C24H24F2N4O5S |
 |
3-Oxo Rosuvastatin SodiuM Salt |
1346606-28-7 |
C22H25FN3NaO6S |
![Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride)](/CAS/20150408/GIF/246021-75-0.gif) |
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) |
246021-75-0 |
C10H16ClN5O2 |
 |
Olopatadine USP RC B |
173174-07-7 |
C21H23NO4 |
![Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid)](/CAS/20180808/GIF/108313-11-7.gif) |
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
108313-11-7 |
C22H30N2O5 |
 |
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-28-2.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
 |
N-carbaMoyl-2-Methyl benzene sulfonaMide |
39051-77-9 |
C8H10N2O3S |
 |
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
![4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride)](/) |
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|
![Ibuprofen IMp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-Methylpropyl)phenyl]butyl]benzene](/) |
Ibuprofen IMp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-Methylpropyl)phenyl]butyl]benzene |
|
|
![3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate](/CAS/GIF/163253-37-0.gif) |
3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate |
163253-37-0 |
C19H20ClF2N3O4 |
 |
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid |
61260-15-9 |
C10H11O5P |
![5-[(4,5-Dihydro-1H-iMidazol-2-yl)aMino]-6-hydroxy-2-Methyl-4(3H)-pyriMidinone](/CAS/GIF/352457-32-0.gif) |
5-[(4,5-Dihydro-1H-iMidazol-2-yl)aMino]-6-hydroxy-2-Methyl-4(3H)-pyriMidinone |
352457-32-0 |
C8H11N5O2 |
 |
ヘキサメタジジン |
1257-19-8 |
C24H34N2O6 |
![3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid](/CAS/GIF/358390-39-3.gif) |
3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid |
358390-39-3 |
C18H20N4O4 |
 |
Metoprolol IMpurity I |
|
C15H25NO3 |
 |
Telmisartan impurity D |
|
|
 |
itraconazole impurity f |
|
|
![N-(5-クロロ-2-ピリジル)-N'-[(1S,2S,4S)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド](/CAS/GIF/1255529-27-1.gif) |
N-(5-クロロ-2-ピリジル)-N'-[(1S,2S,4S)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド |
1255529-27-1 |
C24H30ClN7O4S |
 |
1-(p-Toluenesulfonyl)hoMopiperazine, 95% |
872103-28-1 |
C12H18N2O2S |
![IMp. A (EP) as DisodiuM Salt: (4S)-2-[Carboxy[[[3-(2-chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethylthiazolidine-4-carboxylic Acid DisodiuM Salt(Penicilloic Acids of Flucloxacillin DisodiuM Salt)](/) |
IMp. A (EP) as DisodiuM Salt: (4S)-2-[Carboxy[[[3-(2-chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethylthiazolidine-4-carboxylic Acid DisodiuM Salt(Penicilloic Acids of Flucloxacillin DisodiuM Salt) |
|
|
![4-[3-(トリフルオロメチル)-5-(o-トリル)-1H-ピラゾール-1-イル]ベンゼンスルホンアミド](/CAS/20180808/GIF/170569-99-0.gif) |
4-[3-(トリフルオロメチル)-5-(o-トリル)-1H-ピラゾール-1-イル]ベンゼンスルホンアミド |
170569-99-0 |
C17H14F3N3O2S |
 |
EMpagliflozin iMpurity 6 |
1620758-21-5 |
C32H37ClO12 |
![1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20180629/GIF/138168-36-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
138168-36-2 |
C18H34N4O9 |
 |
ジ-ノルブデソニド(MIXTURE OF DIASTEREOMERS) |
1040085-98-0 |
C23H30O6 |
 |
Linagliptin MethyldiMer |
1418133-47-7 |
C50H56N16O4 |
 |
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
 |
the Metabolite of Ivabradine |
215935-23-2 |
C26H34N2O5 |
 |
parecoxib impurity L |
|
|
 |
Rupatadine iMpurity |
169253-15-0 |
C19H19ClN2 |
 |
ceftazidiMe iMpurity C |
|
|
 |
pidotiMod iMpurity E |
162148-16-5 |
C9H12N2O4S |
![1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-](/CAS/20180808/GIF/1236033-03-6.gif) |
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- |
1236033-03-6 |
C18H20N6O |
![Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-](/CAS/20150408/GIF/145591-80-6.gif) |
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
145591-80-6 |
C11H11NO3 |
![3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)](/CAS/20150408/GIF/477600-76-3.gif) |
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
477600-76-3 |
C15H21N5O |
 |
MeropeneM iMpurity |
96035-23-3 |
C15H19N3O5S |
 |
デスフルオロシプロフロキサシン |
93107-11-0 |
C17H19N3O3 |
 |
Valdecoxib IMpurity-E |
1373038-63-1 |
C16H11Cl2NO5S2 |
 |
Sunitinib N-Oxide |
356068-99-0 |
C22H27FN4O3 |
 |
BendaMustine IMpurity D BendaMustine N-Alkylated IMpurity |
|
|
 |
Cefradine IMpurity E |
|
|
 |
Cetirizine IMpurity-7 |
|
C21H25ClN2O3 |
 |
Dasatinib IMpurity 6 |
|
|
 |
Desacetyl CefathiaMidine |
958001-61-1 |
C17H26N4O5S2 |
 |
Fluconazole IMpurity D |
|
C13H12F2N6O |
 |
Lercanidipine IMpurity A |
74936-74-6 |
C19H22N2O6 |
 |
Loratadine 2-Chloro IMpurity |
165739-64-0 |
C22H22Cl2N2O2 |
 |
Metoprolol IMpurity F |
|
C15H25NO3 |
![1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール](/CAS/20180808/GIF/47363-37-1.gif) |
1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール |
47363-37-1 |
C18H15Cl3N2O |
 |
Milrinone IMpurity 1 |
|
|
 |
Nicardipine Related CoMpound 2 |
64603-72-1 |
C16H14N2O6 |
 |
Saxagliptin IMpurity 1 |
1564266-73-4 |
C6H10N2O |
 |
Sitagliptin DeaMino IMpurity 1 |
1253056-18-6 |
C16H12F6N4O |
 |
Sitagliptin Defuoro IMpurity 5 |
486460-31-5 |
C16H16F5N5O |
 |
TiMolol IMpurity E |
1026075-53-5 |
C17H26N4O6S |
 |
EthanediaMide iMpurity J |
|
C2H4N2O2 |
 |
2-(プロピルチオ)-4,6-ジクロロピリミジン |
1401318-10-2 |
C7H8Cl2N2S |
 |
Istradefylline impurity B |
|
|
 |
Ticagrelor diastereoMer |
1459719-81-3 |
C9H9F2N |
 |
Mirabegron iMpurity |
1581285-26-8 |
C16H21ClN2 |
 |
Sunitinib iMpurity |
356068-98-9 |
C12H19N3O2 |
 |
(-)-ジヒドロビンポセチン |
57327-92-1 |
C22H28N2O2 |
 |
(α1S,α4S,2S,5S)-2,5-DiMethyl-3,6-dioxo-α1,α4-bis(2-phenylethyl)-1,4-piperazinediacetic Acid 1,4-Diethyl Ester |
151387-05-2 |
C30H38N2O6 |
![[2-(4-フルオロフェニル)シクロプロピル]アミン HYDROCHLORIDE](/CAS/GIF/879324-66-0.gif) |
[2-(4-フルオロフェニル)シクロプロピル]アミン HYDROCHLORIDE |
879324-66-0 |
C9H11ClFN |
メタノン](/CAS/GIF/105356-90-9.gif) |
[4-(4-アミノ-7-ヒドロキシ-6-メトキシ-2-キナゾリニル)-1-ピペラジニル](テトラヒドロ-2-フラニル)メタノン |
105356-90-9 |
C18H23N5O4 |
 |
2-(ジエチルアミノ)-N-(2,5-ジメチルフェニル)アセトアミド塩酸塩 |
1012864-23-1 |
C14H23ClN2O |
 |
2-Keto-D-gulonic Acid Methyl Ester |
67776-07-2 |
C7H12O7 |
 |
9,11-Dehydro-17α-cyanoMethyl Estradiol |
86153-38-0 |
C20H23NO2 |
 |
DeMethyl Irbesartan |
158778-58-6 |
C24H26N6O |
 |
Epiprednisolone |
600-90-8 |
C21H28O5 |
 |
Δ-2-CEFODIZIME (〜2:1 C242885 TO C242865) |
120533-30-4 |
C20H20N6O7S4 |
![8-Chloro-1-methyl-6-phenyl-4H-Imidazo[1,5-a][1,4]benzodiazepine](/CAS/GIF/59467-86-6.gif) |
8-Chloro-1-methyl-6-phenyl-4H-Imidazo[1,5-a][1,4]benzodiazepine |
59467-86-6 |
C18H14ClN3 |
 |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C21H25ClO6 |